Articles

Finance
May 16, 2022
Rare Disease Drug Developers Face Bear Market in April
Read More
Finance
May 16, 2022
Kriya Raises $270 Million to Advance Fully Integrated Gene Therapy Engine
Read More
Deals
May 16, 2022
KemPharm to Acquire Orphazyme, Expanding its Rare CNS Diseases Pipeline
Read More
Drug Development
May 16, 2022
Rocket Reports Updates of Data on Multiple Gene Therapy Programs
Read More
RARECast Podcasts
May 13, 2022
Targeting ALS with Synergistic Combinations of Therapies
Read More
Deals
May 13, 2022
BridgeBio Sells Rare Pediatric Disease Priority Review Voucher for $110 Million, Defers Debt Payment
Read More
Drug Development
May 13, 2022
FDA Approves Oral Form of Radicava for Treatment of Adults with ALS
Read More
Drug Development
May 12, 2022
Caribou Reports Positive Initial Data for Gene-Edited Allogeneic CAR-T Cell Therapy
Read More
Deals
May 12, 2022
BridgeBio Licenses SHP2 Inhibitor to Bristol Myers Squibb in Oncology
Read More
Drug Development
May 12, 2022
Takeda Notifies Ovid of Delays in Pivotal Study of Therapy for Rare Epilepsies
Read More

News

May 16, 2022
RARE Global Advocacy Alliance Member Spotlight: Ca...
Read More
May 12, 2022
At a Crossroad for Innovation in Rare Disease
Read More
May 5, 2022
Getting Your Community Ready for Clinical Trials
Read More
May 5, 2022
What Does it Take to Become a Research-Ready Organ...
Read More
May 2, 2022
Cómo puede ayudarle un asesor genético
Read More
May 2, 2022
Pruebas clínicas para encontrar respuestas
Read More
Read more
X